Denkhaus Donald A's Form 4 filing
Catalyst Pharmaceuticals, Inc. (CPRX) · filed Sep 15, 2022
- Accession no.
- 0001161697-22-000458
- Filed
- Sep 15, 2022
- Trade date
- Sep 14, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $306.8K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Denkhaus Donald ACIK 0001278439 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2022 | Common stock, par value $0.001 per share | SSaleDisposed | −20,000 | $15.34F2 | −$306,800 | 297,666 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents a weighted average price for the shares sold. Shares were sold at prices ranging from $15.33 to $15.375 per share.
Referenced by the price of 1 transaction in Table I.